Event overview and recent stock performance Quest Diagnostics (DGX) has been drawing attention after recent share price moves, with the stock down 0.4% over the past day and 1.3% over the past week, ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest ...
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Quest Diagnostics (NYSE:DGX) is partnering with Guardant Health to offer Shield, an FDA-approved blood test for colorectal ...
Quest Diagnostics named Dr. Yuri Fesko, a seasoned health care executive and oncologist, its new senior vice president and chief medical officer. In a Dec. 20 press release announcing the appointment, ...
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced Quest AI Companion, a new AI-powered chat feature that helps individuals analyze, understand and act on ...
Tempe, Ariz.-based Sonora Quest Laboratories, a joint venture between Phoenix-based Banner Health and Madison, N.J.-based lab giant Quest Diagnostics, is partnering with patient financial engagement ...
Zacks Investment Research on MSN
Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound?
A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
[Updated 5/15/2020] Is Quest Diagnostics Or LabCorp The Better Diagnostic Play In The COVID Era? As the U.S. re-opens its economy while trying to contain the spread of the contagious viral infection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results